GRANDPHARMA's half-year profit increased by 51%

HongKong Economic Journal
2024.08.19 14:47

GRANDPHARMA announced that as of the end of June this year, the interim profit attributable to shareholders was HKD 1.558 billion, an annual increase of 51.35%. Earnings per share were 44.41 cents, with no interim dividend declared. During the period, revenue was HKD 6.047 billion, up 0.96% year-on-year. Download the original announcement from the Hong Kong Stock Exchange

Source: HongKong Economic Journal The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.